Literature DB >> 1551489

Cold storage of rat pancreas before purification of islet beta-cells.

G S Korbutt1, D G Pipeleers.   

Abstract

Allotransplantations in rats have demonstrated that aggregates of purified islet endocrine cells are less immunogenic than isolated islets. If purified islet cells are to be tested in humans, their preparation should be feasible from cold-preserved organs. We compared the yield in purified beta-cells from freshly harvested rat pancreases with that from cold-stored organs. After 24 h of preservation in Collins' solution or in University of Wisconsin (UW) solution, the number of purified beta-cells per pancreas was 40% lower (P less than 0.05) than that obtained from nonpreserved controls. Addition of 5 mM benzamidine/4% bovine serum albumin to Collins' solution resulted in similar recoveries as with freshly harvested organs; this addition did not increase the yield from UW solution-stored organs. When compared to preparations from fresh pancreases, islets and islet cells isolated from pancreases preserved in Collins' solution-bovine serum albumin-benzamidine were comparable in structural integrity, viability in culture, secretory responsiveness in vitro, and capability of correcting hyperglycemia in streptozocin-induced diabetic rats. We conclude that addition of benzamidine to Collins' preservation solution allows purification of islet beta-cells from 24-h-preserved rat pancreases in the same yield and quality as from freshly harvested organs. These results indicate that cold-preserved pancreases can be used for the preparation of purified islet cell grafts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551489     DOI: 10.2337/diab.41.3.299

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  Large scale isolation, growth, and function of porcine neonatal islet cells.

Authors:  G S Korbutt; J F Elliott; Z Ao; D K Smith; G L Warnock; R V Rajotte
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

2.  The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells.

Authors:  C T Bussiere; J R T Lakey; A M J Shapiro; G S Korbutt
Journal:  Diabetologia       Date:  2006-08-09       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.